In Vitro Activities of the New Antifungal Triazole SCH 56592 against Common and Emerging Yeast Pathogens

A broth microdilution method performed in accordance with the National Committee for Clinical Laboratory Standards guidelines was used to compare the in vitro activity of the new antifungal triazole SCH 56592 (SCH) to that of fluconazole (FLC), itraconazole (ITC), and ketoconazole (KETO) against 257...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Barchiesi, Francesco, Arzeni, Daniela, Fothergill, Annette W., Di Francesco, Luigi Falconi, Caselli, Francesca, Rinaldi, Michael G., Scalise, Giorgio
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 2000
Sujets:	Susceptibility
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89662/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10602757/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.1.226-229.2000
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!